Cargando…
Personalised Medicine and the Economy of Biotechnological Promise
Rather than seek to distinguish hype from legitimate promise, it may be more helpful to think about personalised medicine as embodying a promissory economy which serves both to mobilize resources for research and — partly at least — to determine the ends to which that research is directed. Personali...
Autor principal: | Sturdy, Steve |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Routledge
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5448396/ https://www.ncbi.nlm.nih.gov/pubmed/28517983 http://dx.doi.org/10.1080/20502877.2017.1314892 |
Ejemplares similares
-
The Promise and the Hype of ‘Personalised Medicine’
por: Maughan, Tim
Publicado: (2017) -
Personalised nutrition technologies: a new paradigm for dietetic practice and training in a digital transformation era
por: Abrahams, M., et al.
Publicado: (2020) -
Pharmaceutical development and optimization of azithromycin suppository for paediatric use
por: Kauss, Tina, et al.
Publicado: (2013) -
Preclinical evaluation of thermoreversible triamcinolone acetonide hydrogels for drug delivery to the inner ear
por: Engleder, Elisabeth, et al.
Publicado: (2014) -
Significance of measurement of serum trough level and anti‐drug antibody of adalimumab as personalised pharmacokinetics in patients with Crohn's disease: a subanalysis of the DIAMOND trial
por: Nakase, H., et al.
Publicado: (2017)